Solid Biosciences

BiotechnologySeries CUSsolidbio.com

Latest round

Series C

Last raised

Mar 2017

Total raised

$93M

Investors

9

About Solid Biosciences

Founded in 2013 and based in Massachusetts, US, Solid Biosciences Inc. operates as a biotechnology company that develops novel treatments for patients with Duchenne muscular dystrophy.

Who invested in Solid Biosciences

9 investors across 2 rounds

See all investors in Solid Biosciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 30, 2017

    Amount

    $50M

    Investors

    Locked

  2. Series B

    Nov 3, 2015

    Amount

    $43M

    Investors

    Locked

Questions about Solid Biosciences

Who invested in Solid Biosciences?

Solid Biosciences has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Solid Biosciences raised?

Solid Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Solid Biosciences last raise money?

Solid Biosciences's most recent round on record is a Series C, in Mar 2017.

What does Solid Biosciences do?

Founded in 2013 and based in Massachusetts, US, Solid Biosciences Inc.

Where is Solid Biosciences headquartered?

Solid Biosciences is headquartered in US.

Which VCs invest in companies like Solid Biosciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Solid Biosciences's stage. Their profiles are linked below.

Raising like Solid Biosciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.